Healthier Choices Management Corp. offers nutritional products and health management services but faces severe financial distress with zero reported revenue in the most recent fiscal year.
An investor might consider this stock only if they believe the company's dormant assets and brand equity can be revitalized through a strategic turnaround or asset sale to address the current operational freeze. The massive financing cash inflows suggest potential access to capital markets that could fund a restructuring of the discontinued business segments.
The stock is highly risky as the company recorded zero revenue in 2024 and carries a significant retained earnings deficit, indicating deep-seated financial instability. Negative operating profit of $-8.5M and negative net income of $-11.9M demonstrate an inability to generate sustainable earnings from current operations.
Healthier Choices Management Corp. specializes in the provision of nutritional products and health management services, primarily targeting markets focused on dietary wellness and therapeutic nutrition. The company has recently reported a significant contraction in total revenue to effectively zero dollars in 2024 following a peak in 2023, while managing substantial operating losses and negative cash flows from discontinued operations.
Management has faced an unprecedented downturn where the company's reported revenue dropped from $55.7M in 2023 to zero in 2024, coinciding with a net loss of $11.9M. Cash flow from operations turned negative at $-3.7M, and despite receiving $4.7M in financing cash flows, the company's cash position deteriorated from $4.2M to $1.7M over the period. The financial statements reflect a substantial drag from discontinued operations with losses of $3.8M, suggesting the core business model may have been fundamentally disrupted or voluntarily halted.
The health and wellness industry is generally robust but faces intense competition from established giants and emerging direct-to-consumer brands that can operate with higher efficiency margins. Companies in this sector typically require consistent product innovation and supply chain management, which appears to have faltered for this specific entity given the recent revenue collapse.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $29.3M | $55.7M | $501 |
| Cost of Revenue | $19.0M | $35.3M | $66.8K |
| Gross Profit | $10.2M | $20.3M | $-66.3K |
| Operating Expenses | $18.9M | $38.3M | $8.4M |
| Operating Income | $-8.7M | $-18.0M | $-8.5M |
| G&A | — | $1.0M | $1.0M |
| Stock-Based Comp | $72.2K | $3.4M | $4.6M |
| D&A | $1.1M | $1.5M | $1.1M |
| Depreciation | $300.0K | $600.0K | $25.0K |
| Amortization | $800.0K | $900.0K | $40.0K |
| Other OpEx | — | $37.3M | $7.4M |
| Non-Operating Income | $0 | $0 | $0 |
| Interest Income | $59.0K | $178.0K | — |
| Pre-Tax Income | $-8.7M | $-18.0M | $-8.5M |
| Income Tax | $0 | $507.2K | $-388.4K |
| Continuing Ops | $-8.7M | $-18.5M | $-8.1M |
| Discontinued Ops | $0 | $0 | $-3.8M |
| Net Income | $-7.2M | $-18.5M | $-11.9M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-7.2M | $-18.5M | $-11.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $30.3M | $11.7M | $1.9M |
| Cash & Equivalents | — | — | $1.2M |
| Marketable Securities | $9.8K | — | — |
| Accounts Receivable | $55.8K | $128.2K | — |
| Inventory | $3.8M | $4.2M | $40.5K |
| Other Current Assets | $26.4M | $7.4M | $714.8K |
| Long-Term Assets | $24.9M | $19.2M | $271.6K |
| PP&E (Net) | $3.1M | $2.7M | $80.5K |
| Goodwill | $5.7M | — | — |
| Operating Leases | $10.6M | $11.5M | $4.4K |
| Other LT Assets | $5.5M | $5.0M | $186.7K |
| Total Assets | $55.3M | $31.0M | $2.2M |
| Current Liabilities | $9.9M | $12.2M | $2.7M |
| Current Debt | $536.5K | $1.2M | — |
| Current Leases | $2.2M | $2.8M | $3.1K |
| Deferred Revenue | $198.6K | $207.5K | — |
| Other Current Liab | $6.9M | $6.5M | $2.7M |
| Long-Term Liabilities | $10.4M | $10.9M | $1.3K |
| Long-Term Debt | $2.4M | $2.4M | — |
| LT Operating Leases | $8.0M | $8.5M | $1.3K |
| Other LT Liab | $-453.2K | $-453.2K | $-453.2K |
| Total Liabilities | $20.3M | $23.1M | $2.7M |
| Shareholders' Equity | $34.9M | $7.9M | $-450.1K |
| Paid-In Capital | $29.0M | $21.0M | $25.3M |
| Retained Earnings | $-43.6M | $-62.1M | $-75.0M |
| Total L&E | $55.3M | $31.0M | $2.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-7.2M | $-18.5M | $-11.9M |
| Non-Cash Adjustments | $-3.4M | $13.1M | $9.1M |
| Working Capital Changes | $6.8M | $691.7K | $-819.2K |
| Cash from Operations | $-3.9M | $-4.7M | $-3.7M |
| Capital Expenditures | $480.9K | $184.3K | $192.9K |
| Cash from Investing | $-10.7M | $-768.6K | $-4.9M |
| Cash from Financing | $12.8M | $-13.5M | $4.7M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-1.8M | $-19.1M | $-3.9M |
| Beginning Cash | $26.5M | $24.7M | $4.2M |
| Ending Cash | $24.7M | $5.6M | $1.7M |
The company's historical revenue streams appear to have been concentrated in direct-to-consumer or wholesale nutritional product sales, evidenced by the 2023 revenue peak before a complete cessation of reported operations. A significant portion of the financial structure indicates heavy investment in discontinued operations which generated substantial losses alongside current operating expenses.
Severe liquidity crisis with negative net cash change of $3.9M and a retained earnings deficit exceeding $75M threatening solvency. Complete operational halt indicated by zero revenue in 2024 suggests a potential loss of market share and customer base. Significant reliance on financing cash flows to cover operating deficits, creating a unsustainable burn rate without external capital injection. High accumulated losses from discontinued operations indicating structural business model failure or strategic retreat.
Potential niche expertise in specific therapeutic nutrition formulations that may still hold value despite current operational shutdowns. Access to established supply chains for health and wellness products accumulated during periods of active revenue generation. A specialized brand portfolio focused on dietary management that could be reactivated or licensed if market conditions stabilize.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.